Ispire Technology Inc. (ISPR)
| Market Cap | 99.87M -28.6% |
| Revenue (ttm) | 89.46M -38.2% |
| Net Income | -34.17M |
| EPS | -0.60 |
| Shares Out | 57.40M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,333 |
| Open | 1.660 |
| Previous Close | 1.680 |
| Day's Range | 1.650 - 1.740 |
| 52-Week Range | 1.010 - 3.870 |
| Beta | 2.05 |
| Analysts | Strong Buy |
| Price Target | 5.00 (+187.36%) |
| Earnings Date | Sep 14, 2026 |
About ISPR
Ispire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Ispire and Aspire brands. The company was founded in 2010 and is headquartered in Los Angeles, California. Ispire Technology Inc. is a subsidiary of Pride Worldwide Investment Limited.
Financial Performance
In fiscal year 2025, Ispire Technology's revenue was $127.49 million, a decrease of -16.07% compared to the previous year's $151.91 million. Losses were -$39.24 million, 165.7% more than in 2024.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for ISPR stock is "Strong Buy." The 12-month stock price target is $5.0, which is an increase of 187.36% from the latest price.
News
Ispire Technology initiated with a Buy at BTIG
BTIG analyst Owen Bennett initiated coverage of Ispire Technology (ISPR) with a Buy rating and $3.50 price target Ispire is well positioned to capture a growing share of the expanding…
Ispire Technology Transcript: AGM 2026
The meeting covered director elections and auditor ratification, with all proposals approved. Voting procedures and governance protocols were detailed, and no third-party proposals were presented. Risks related to forward-looking statements were acknowledged.
Ispire Technology forms joint venture to enter nicotine pouch market
Ispire Technology (ISPR) has entered into a joint venture with Shandong Jincheng Pharma, a global pharmaceutical company, to manufacture and commercialize nicotine pouch products. The joint venture ma...
Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma
Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments LOS ANGELES, May 12, 2026 /PRNewswire/ -- I...
Ispire Technology Proxy statement: Proxy filing
Ispire Technology filed a proxy statement on May 12, 2026, providing details for shareholder voting and corporate governance matters.
Ispire Technology Proxy statement: Proxy filing
Ispire Technology filed a proxy statement on May 12, 2026, providing details for shareholder voting and corporate governance matters.
Ispire Technology reports Q3 EPS (17c) vs. (19c) last year
Reports Q3 revenue $18.7M vs. $26.2M last year. Co-CEO Michael Wang commented, “This quarter reflects the successful stabilization of our business and with cash growing sequentially by $468K to $18M,…
Ispire Technology Earnings Call Transcript: Q3 2026
Revenue declined year-over-year but sequential cash increased, reflecting improved discipline and a solid foundation. Malaysia manufacturing and proprietary tech position the business for margin gains and future growth, with profitability targeted in the second half of 2026.
Ispire Technology Earnings release: Q3 2026
Ispire Technology released its Q3 2026 earnings on May 7, 2026, summarizing the period's financial results.
Ispire Technology Quarterly report: Q3 2026
Ispire Technology has published its Q3 2026 quarterly earnings report on May 7, 2026.
Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2026
Cash Increased Sequentially by $468,000 to $18 Million Plans to Achieve Cash Flow Positive in Second Half of Calendar Year 2026 Business Stabilized Following Strategic Repositioning Phased Roadmap Tar...
Ispire Technology Inc. Schedules Fiscal Third Quarter 2026 Earnings Conference Call
LOS ANGELES, May 1, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host i...
IKETech Wins "Privacy-Centric Age Assurance Solution of the Year," Recognized for Innovation at Global Industry Awards
Dual honors at GAAS Summit underscore growing regulatory and commercial validation for IKETech's point-of-use, privacy-first compliance platform LOS ANGELES, April 23, 2026 /PRNewswire/ -- IKETech LLC...
IKE Tech Engages FDA on Next-Generation Compliance Infrastructure for ENDS
Companies outline public health case for point-of-use enforcement technologies and call for regulatory framework recognizing compliance software as a tobacco product LOS ANGELES, April 9, 2026 /PRNews...
Ispire highlights market opportunity established by FDA draft guidance
Ispire Technology (ISPR) highlighted the economic value and multi-billion-dollar market opportunity created for its shareholders by the U.S. Food and Drug Administration’s, FDA, newly issued draft gui...
Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value
FDA establishes first-ever framework for flavored ENDS, recognizing device level age verification as a regulatory requirement FDA guidance unlocks an estimated $50 billion total addressable market, al...
Ispire Technology Inc. to Participate in the 38th Annual ROTH Conference
LOS ANGELES, March 11, 2026 /PRNewswire/ -- Ispire Technology Inc. ( NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today annou...
Ispire Technology Earnings Call Transcript: Q2 2026
Q2 2026 saw revenue decline due to a strategic pivot to high-value nicotine clients, but key metrics like net loss, operating expenses, and accounts receivable improved. Innovations in age-gating and G-Mesh technology, plus Malaysian facility expansion, position the company for future growth.
Ispire Technology Earnings release: Q2 2026
Ispire Technology released its Q2 2026 earnings on February 6, 2026, summarizing the period's financial results.
Ispire Technology Quarterly report: Q2 2026
Ispire Technology has published its Q2 2026 quarterly earnings report on February 6, 2026.
Ispire Technology reports Q2 (12c) vs. (14c) last year
Sees Q2 revenue $20.3M vs. $41.8M last year. “This quarter represented an inflection point for Ispire during its yearlong cost cutting and customer quality rationalization efforts and we believe futur...
Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026
Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025 Cash of $17.6 Million at December 31, 2025 LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Techno...
Ispire-Backed IKE Tech Invited to Participate in FDA Roundtable on PMTA Submissions
Invitation-Only Forum Underscores FDA Recognition of IKE Tech as a Key Stakeholder and Highlights the Strategic Role of Age-Gating Technology in the Future of ENDS Regulation and Compliance LOS ANGELE...
Ispire Technology Inc. Schedules Fiscal Second Quarter 2026 Earnings Conference Call
LOS ANGELES, Feb. 3, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will hos...
Ispire Technology Unveils Next-Gen Cannabis Hardware Ecosystem at MJBizCon 2025
Company to Showcase Fully Reengineered Portfolio; Executive Team, Including Head of Sales John Monds, Available for On-Site Meetings LOS ANGELES , Nov. 26, 2025 /PRNewswire/ -- Ispire Technology Inc...